Polygenic Risk Scores Predicting Estimated GFR Validated With Iohexol Clearance
SNVs with non-GFR effects on creatinine and cystatin-C influence GWAS results. The results of GWAS using eGFR should be validated using experimental and other more precise methods.
Authors
- Stein Hallan (ORCID: https://orcid.org/0000-0002-9045-3569)
- Viji Nair (ORCID: https://orcid.org/0000-0003-1657-954X)
- Inger Therese Enoksen (ORCID: https://orcid.org/0000-0003-1275-7492)
- Toralf Melsom (ORCID: https://orcid.org/0000-0003-0764-4813)
- Ludvig Balteskard Rinde (ORCID: https://orcid.org/0000-0002-1621-1756)
- M. Kretzler
- Björn O. Eriksen (ORCID: https://orcid.org/0000-0002-5837-2806)
- Jon V.N. Porserud
Institutions
- University Hospital of North Norway (NO)
- Norwegian University of Science and Technology (NO)
- University of Michigan (US)
- St Olav's University Hospital (NO)
- UiT The Arctic University of Norway (NO)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1016/j.ekir.2025.10.016
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00